
Invictus Energy is progressing its Cabora Bassa gas project in Zimbabwe, with Mukuyu appraisal and Musuma-1 drilling as key catalysts. While the PPSA reduces regulatory risk, IVZ remains a volatile, pre-revenue explorer reliant on external funding.
.webp&w=828&q=75)
Learn how bull and bear markets shape prices, investor sentiment and trading decisions, with practical indicators, strategies and risk-management techniques to help identify market phases and adapt to changing conditions.

Lumos Diagnostics continues to expand its commercial footprint through FDA clearance, growing U.S. adoption, manufacturing partnerships, and paediatric research. The company now focuses on turning regulatory success and market access into recurring sales, broader reimbursement, and sustainable long-term growth.

EchoIQ is expanding its US presence through new funding, partnerships, clinical research, and hospital deployments. Its AI-based cardiac software continues to gain commercial traction, while the chart shows a pullback to key support within a longer-term rising trend.
.webp&w=828&q=75)
Wildcat Resources (ASX: WC8) advances its Pilbara lithium portfolio with expanding high-grade discoveries, a progressing DFS at Tabba Tabba, and strong cash reserves, positioning the company for transformational growth amid rising global lithium demand.
.webp&w=828&q=75)
Brambles (ASX: BXB) compounds cash flow and margins through operational excellence, asset efficiency and disciplined capital allocation, supported by buy‑backs and a strengthening customer value proposition.